Literature DB >> 6287014

Use of a hybrid infectivity assay to analyze primary transcription of temperature-sensitive mutants of the New Jersey serotype of vesicular stomatitis virus.

H D Isle, S U Emerson.   

Abstract

A hybrid infectivity assay specific for primary transcription was developed to analyze the production of functional mRNAs by vesicular stomatitis virus. A template prepared from wild-type virions of the New Jersey serotype of vesicular stomatitis virus was reconstituted with RNA polymerase proteins from the wild type or temperature-sensitive mutants, and the in vivo temperature sensitivity of the polymerase was determined by infectivity assay. The data demonstrate that the New Jersey temperature-sensitive mutants A1 and E1 have non-temperature-sensitive transcriptases, whereas the B1 and F1 mutants both have temperature-sensitive L proteins which are defective in primary transcription.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6287014      PMCID: PMC256093     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  8 in total

1.  Proposed replicative role of the NS polypeptide of vesicular stomatitis virus: structural analysis of an electrophoretic variant.

Authors:  J A Lesnaw; L R Dickson; R H Curry
Journal:  J Virol       Date:  1979-07       Impact factor: 5.103

2.  Effect of temperature-sensitive mutation on activity of the RNA transcriptase of vesicular stomatitis virus New Jersey.

Authors:  J F Szilágyi; C R Pringle
Journal:  J Virol       Date:  1979-06       Impact factor: 5.103

3.  Temperature-sensitive mutants of complementation group E of vesicular stomatitis virus New Jersey serotype possess altered NS polypeptides.

Authors:  D Evans; C R Pringle; J F Szilágyi
Journal:  J Virol       Date:  1979-08       Impact factor: 5.103

4.  RNA synthesis by temperature-sensitive mutants of vesicular stomatitis virus, New Jersey serotype.

Authors:  J A Lesnaw; M E Reichmann
Journal:  Virology       Date:  1975-02       Impact factor: 3.616

5.  Both NS and L proteins are required for in vitro RNA synthesis by vesicular stomatitis virus.

Authors:  S U Emerson; Y Yu
Journal:  J Virol       Date:  1975-06       Impact factor: 5.103

6.  Rebinding of transcriptase components (L and NS proteins) to the nucleocapsid template of vesicular stomatitis virus.

Authors:  M G Mellon; S U Emerson
Journal:  J Virol       Date:  1978-09       Impact factor: 5.103

Review 7.  Vesicular stomatitis virus: mode of transcription.

Authors:  A D Banerjee; G Abraham; R J Colonno
Journal:  J Gen Virol       Date:  1977-01       Impact factor: 3.891

8.  Isolation and characterization of temperature-sensitive mutants of vesicular stomatitis virus, New Jersey serotype.

Authors:  C R Pringle; I B Duncan; M Stevenson
Journal:  J Virol       Date:  1971-12       Impact factor: 5.103

  8 in total
  5 in total

1.  Assignment of the temperature-sensitive lesion in the replication mutant A1 of vesicular stomatitis virus to the N gene.

Authors:  M D Marks; J Kennedy-Morrow; J A Lesnaw
Journal:  J Virol       Date:  1985-01       Impact factor: 5.103

2.  Continuing coevolution of virus and defective interfering particles and of viral genome sequences during undiluted passages: virus mutants exhibiting nearly complete resistance to formerly dominant defective interfering particles.

Authors:  N J DePolo; C Giachetti; J J Holland
Journal:  J Virol       Date:  1987-02       Impact factor: 5.103

Review 3.  Transcription and replication of rhabdoviruses.

Authors:  A K Banerjee
Journal:  Microbiol Rev       Date:  1987-03

4.  Primary structure of the vesicular stomatitis virus polymerase (L) gene: evidence for a high frequency of mutations.

Authors:  M Schubert; G G Harmison; E Meier
Journal:  J Virol       Date:  1984-08       Impact factor: 5.103

5.  Aberrant polyadenylation by a vesicular stomatitis virus mutant is due to an altered L protein.

Authors:  D M Hunt; E F Smith; D W Buckley
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.